SCHEMBL6016950

SCHEMBL6016950

O=C(Nc1ccc(Cc2nc(Cl)[c]c(Cl)n2)cc1)c1ccc2ccccc2c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.59
DEGS1 O15121 1/20 0.55
NPC1 O15118 5/20 0.54
RAB9A P51151 5/20 0.54
KDM4E B2RXH2 1/20 0.54
KMT2A Q03164 5/20 0.54
MEN1 O00255 4/20 0.54
GPR27 Q9NS67 1/20 0.53
CASP3 P42574 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
TDP1 Q9NUW8 1/20 0.51
PTGDR2 Q9Y5Y4 7/20 0.50
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
MCL1 Q07820 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PLAU P00749 1/20 0.48
F10 P00742 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6016986 0.90 NR1H4 (0.51) NR1H4DEGS1NPC1RAB9AKDM4E
SCHEMBL6016894 0.88 KMT2A (0.50) NR1H4DEGS1NPC1RAB9AKDM4E
SCHEMBL5961396 0.88 RAB9A (0.50) NR1H4DEGS1NPC1RAB9AKDM4E
SCHEMBL5961335 0.87 NR1H4 (0.48) NR1H4DEGS1NPC1RAB9AKDM4E
SCHEMBL6016969 0.87 RAB9A (0.57) NR1H4DEGS1NPC1RAB9AKDM4E
SCHEMBL6886843 0.87 KMT2A (0.49) NR1H4DEGS1NPC1RAB9AKDM4E
SCHEMBL6016983 0.86 NR1H4 (0.47) NR1H4DEGS1NPC1RAB9AKDM4E
SCHEMBL6886123 0.85 RAB9A (0.61) NR1H4DEGS1NPC1RAB9AKMT2A
SCHEMBL5961323 0.84 NPC1 (0.47) NR1H4DEGS1NPC1RAB9AKDM4E
SCHEMBL6016891 0.83 TRPV1 (0.45) NR1H4DEGS1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633726-A1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 Actimis Pharmaceuticals, Inc., (US) 2006-03-15 EP disclosed
WO-2004096777-A1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 ACTIMIS PHARMACEUTICALS, INC. (US) 2004-11-11 WO disclosed